Welcome to CEVHAP

Welcome to CEVHAP

The Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) was established in October 2010 as a multidisciplinary body to advocate for public policy reforms that reduce the burden of viral hepatitis in Asia-Pacific.

CEVHAP is the first organisation based in the Asia Pacific region to dedicate its efforts to this cause.

The organisation is committed to building partnerships with others who share the same goals including: governments, NGOs, the business sector, academic researchers, civil society and people themselves who are infected.

Viral hepatitis - It's closer than you think. One million people die from viral hepatitis in Asia Pacific every year.  On WORLD HEPATITIS DAY CEVHAP urges governments to embrace WHO’s new Global Framework for Action.             >> READ MORE
FaLang translation system by Faboba
Connect with us     connect with CEVHAP           

 CEVHAP-CUHK Hepatitis Policy in Asia June 2017

>> Viral Hepatitis Asia Survey 2016

 

nohep.logo_horizontal.jpg

NOhep is a global, grassroots movement aimed at bringing all stakeholders together to eliminate viral hepatitis by 2030. It has been developed to create global awareness of the disease, similar to the red ribbon for HIV/AIDS, and was launched in 2016. NOhep firmly positions itself at the forefront of the elimination conversation, showcasing exemplary leadership, fostering on-the-ground innovative solutions and taking action to support the policy changes needed to eliminate this cancer-causing illness by 2030. Being a part of NOhep means being part of the solution. (To find out more about the development of this exciting initiative, watch this short video: https://youtu.be/Oer-rGwnKZU

 

CEVHAP Activity Report Brochure EMAIL smaller Cover

>> FAST FACTS
Viral Hepatitis
  Globally, 2 billion people have been
infected with hepatitis B virus, with an
estimated 600,000 dying each year . . .
  The number of people with chronic
hepatitis C and more advanced liver
disease or cirrhosis, is projected to
increase by 38% between 2006 and 2015
unless the number of people being
treated increases substantially.
  There is no vaccine for hepatitis C but
approximately 80% of patients who are
able to complete recommended
treatment, are cured . . .
>> FEATURED VIDEOS 
Why hepatitis policy matters - the story of Baltazar Lucas  
 
Video What are the dangers of viral #hepatitis? Hear what #CEVHAP Chair Prof Ding-Shinn Chen had to say to the Wall Street Journal.
  
A Message from DS Chen
Chairman, CEVHAP